Treatment for Group D Streptococcal Infections
The treatment of choice for Group D streptococcal infections is a combination of penicillin or ampicillin with an aminoglycoside (such as gentamicin) for synergistic bactericidal activity, particularly in serious infections like endocarditis. 1
Treatment Regimens Based on Infection Type
For Endocarditis
- First-line therapy:
For Less Severe Infections
- Oral therapy options:
For Penicillin-Allergic Patients
- Alternative regimens:
Important Considerations
Antimicrobial Resistance
- Group D streptococci can develop high-level resistance to aminoglycosides (found in approximately 12% of Enterococcus faecalis strains) 4
- No penicillin resistance has been documented in Group A streptococci, but this doesn't necessarily apply to Group D 1
- When treating serious infections, susceptibility testing is crucial to guide therapy 2
Monitoring During Treatment
- For patients receiving gentamicin:
- Monitor renal function and serum gentamicin concentrations weekly
- Pre-dose (trough) concentrations should be <1 mg/L
- Post-dose (peak) serum concentrations should be 10-12 mg/L 1
- For patients receiving vancomycin:
- Pre-dose (trough) levels should be 10-15 mg/L
- Post-dose (peak) levels should be 30-45 mg/L 1
Special Situations
- For prosthetic valve endocarditis:
- For neonatal sepsis:
Treatment Algorithm
Assess severity of infection:
- Life-threatening/invasive (endocarditis, meningitis, sepsis): Use IV combination therapy
- Non-severe/localized: Consider oral monotherapy
Check for penicillin allergy:
- No allergy: Use penicillin-based regimens
- Allergy present: Use alternative regimens (vancomycin, clindamycin)
Obtain cultures and susceptibility testing before or at initiation of therapy to guide treatment 2
Monitor clinical response:
- If improving: Complete full course of antibiotics
- If not improving after 48-72 hours: Reassess diagnosis, consider resistance, and adjust therapy accordingly
Common Pitfalls
- Inadequate duration of therapy: Ensure complete course even if symptoms resolve quickly
- Failure to use combination therapy for serious infections: The synergistic effect of penicillin plus aminoglycoside is crucial for treating severe Group D streptococcal infections 1, 5
- Not monitoring for aminoglycoside toxicity: Regular monitoring of renal function and drug levels is essential
- Misidentification of the organism: Group D streptococci include both enterococci and non-enterococci (like S. bovis), which may have different resistance patterns 4
Remember that medical failure may occur despite appropriate antibiotic therapy, particularly in endocarditis cases, and surgical intervention may be necessary in these situations 5.